Clive A. Meanwell
2009
In 2009, Clive A. Meanwell earned a total compensation of $2M as Chairman and Chief Executive Officer at Medicines, a 33% decrease compared to previous year.
Compensation breakdown
Bonus | $441,480 |
---|---|
Salary | $588,640 |
Stock Awards | $993,757 |
Other | $1,794 |
Total | $2,025,671 |
Meanwell received $993.8K in stock awards, accounting for 49% of the total pay in 2009.
Meanwell also received $441.5K in bonus, $588.6K in salary and $1.8K in other compensation.
Rankings
In 2009, Clive A. Meanwell's compensation ranked 2,342nd out of 9,885 executives tracked by ExecPay. In other words, Meanwell earned more than 76.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,342 out of 9,885 | 76th |
Division Manufacturing | 819 out of 3,690 | 78th |
Major group Chemicals And Allied Products | 159 out of 866 | 82nd |
Industry group Drugs | 93 out of 638 | 85th |
Industry Pharmaceutical Preparations | 73 out of 446 | 84th |
Source: SEC filing on April 27, 2012.
Meanwell's colleagues
We found five more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2009.
2009
John Kelley
Medicines
Chief Operating Officer
2009
Glenn Sblendorio
Medicines
Chief Financial Officer
2009
Paul Antinori
Medicines
General Counsel
2009
William O'Connor
Medicines
Chief Accounting Officer
2009
Catharine Newberry
Medicines